Author:
Cavinato Lara,Pegoraro Matteo,Ragni Alessandra,Sollini Martina,Erba Paola Anna,Ieva Francesca
Abstract
AbstractPersonalized medicine is the future of medical practice. In oncology, tumor heterogeneity assessment represents a pivotal step for effective treatment planning and prognosis prediction. Despite new procedures for DNA sequencing and analysis, non-invasive methods for tumor characterization are needed to impact on daily routine. On purpose, imaging texture analysis is rapidly scaling, holding the promise to surrogate histopathological assessment of tumor lesions. In this work, we propose a tree-based representation strategy for describing intra-tumor heterogeneity of patients affected by metastatic cancer. We leverage radiomics information extracted from PET/CT imaging and we provide an exhaustive and easily readable summary of the disease spreading. We exploit this novel patient representation to perform cancer subtyping according to hierarchical clustering technique. To this purpose, a new heterogeneity-based distance between trees is defined and applied to a case study of prostate cancer. Clusters interpretation is explored in terms of concordance with severity status, tumor burden and biological characteristics. Results are promising, as the proposed method outperforms current literature approaches. Ultimately, the proposed method draws a general analysis framework that would allow to extract knowledge from daily acquired imaging data of patients and provide insights for effective treatment planning.
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Fisher, R., Pusztai, L. & Swanton, C. Cancer heterogeneity: Implications for targeted therapeutics. Br. J. Cancer 108, 479–485 (2013).
2. Stanta, G. & Bonin, S. Overview on clinical relevance of intra-tumor heterogeneity. Front. Med. 5, 85 (2018).
3. y Cajal, S. R. et al. Clinical implications of intratumor heterogeneity: Challenges and opportunities. J. Mol. Med. 98, 161–177 (2020).
4. Cummings, M. C. et al. Metastatic progression of breast cancer: Insights from 50 years of autopsies. J. Pathol. 232, 23–31 (2014).
5. Esparza-López, J., Escobar-Arriaga, E., Soto-Germes, S. & de Jesús Ibarra-Sánchez, M. Breast cancer intra-tumor heterogeneity: One tumor, different entities. Rev. Invest. Clin. 69, 66–76 (2017).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献